These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7504313)
1. [Pharmacological properties of aprotinin and its therapeutic use in heart surgery]. Carrera A; Fernández P; García del Valle S; de la Quintana B; Martínez MV Rev Esp Anestesiol Reanim; 1993; 40(5):292-9. PubMed ID: 7504313 [TBL] [Abstract][Full Text] [Related]
2. The serine antiprotease aprotinin (Trasylol): a novel approach to reducing postoperative bleeding. Royston D Blood Coagul Fibrinolysis; 1990; 1(1):55-69. PubMed ID: 1715200 [TBL] [Abstract][Full Text] [Related]
3. [Effect of low dose aprotinin on reduction of blood loss after extracorpreal circulation]. Takahashi K; Hoshino S; Iwaya F; Igari T; Satokawa H; Ono T; Takase S; Ogawa T; Satoh K; Satoh K; Misawa Y; Ishikawa K Kyobu Geka; 2000 Dec; 53(13):1085-90. PubMed ID: 11127552 [TBL] [Abstract][Full Text] [Related]
5. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy. Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877 [TBL] [Abstract][Full Text] [Related]
6. [Effect of acute aprotinin (Gordox) therapy on hemostasis in heart surgery patients, with special reference to hyperfibrinolysis]. Szécsi J; Bátonyi E; Rédai I; Szabó Z; Herman K; Liptay P; Medgyessy I; Péterffy A Orv Hetil; 1990 Dec; 131(51):2809-14. PubMed ID: 1702885 [TBL] [Abstract][Full Text] [Related]
7. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages. Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399 [TBL] [Abstract][Full Text] [Related]
8. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462 [TBL] [Abstract][Full Text] [Related]
9. [Antifibrinolytic agents and extracorporeal circulation]. Gomes OM; Freitas Neto AG; Wolosker M; Langer B; Dubieu WK; Zerbini EJ Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):209-13. PubMed ID: 4538812 [No Abstract] [Full Text] [Related]
10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
11. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass. Donahue MA; Price PM Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841 [TBL] [Abstract][Full Text] [Related]
12. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. McEvoy MD; Reeves ST; Reves JG; Spinale FG Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372 [TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414 [TBL] [Abstract][Full Text] [Related]
14. [Hemostatic mechanism associated with aprotinin during and after the extracorporeal circulation for cardiac and great vessel surgery]. Takaori M; Fukui A; Kimura K; Mihira M; Endou S; Fujiwara T Masui; 1995 Dec; 44(12):1661-6. PubMed ID: 8583662 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibrinolysis during extracorporeal circulation. Katz W; Mammen EF; Thal AP Surg Forum; 1965; 16():63-4. PubMed ID: 5294432 [No Abstract] [Full Text] [Related]
16. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss. Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611 [TBL] [Abstract][Full Text] [Related]
17. Protease activated receptors: clinical relevance to hemostasis and inflammation. Landis RC Hematol Oncol Clin North Am; 2007 Feb; 21(1):103-13. PubMed ID: 17258121 [TBL] [Abstract][Full Text] [Related]